1984
DOI: 10.1016/0090-6980(84)90035-2
|View full text |Cite
|
Sign up to set email alerts
|

6,7,4′-trihydroxyisoflavan: A potent and selective inhibitor of 5-lipoxygenase in human and porcine peripheral blood leukocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0
1

Year Published

1988
1988
2007
2007

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(12 citation statements)
references
References 27 publications
0
11
0
1
Order By: Relevance
“…The presence of these compounds, to some extent, explains the uses of M. unguis-cati preparations in folk medicine. Lupeol showed in- (Alves et al 1997), and lupeol, b-sitosterol and b-sitosterylglucoside showed anti-in¯ammatory and antipyretic effects (Kuhl et al 1984;Davis et al 1994). In addition, a mixture of b-sitosterol and b-sitosterylglucoside can be found as components of prescriptions used against prostate diseases, for example Harzol (Henneking & Heckers 1983).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The presence of these compounds, to some extent, explains the uses of M. unguis-cati preparations in folk medicine. Lupeol showed in- (Alves et al 1997), and lupeol, b-sitosterol and b-sitosterylglucoside showed anti-in¯ammatory and antipyretic effects (Kuhl et al 1984;Davis et al 1994). In addition, a mixture of b-sitosterol and b-sitosterylglucoside can be found as components of prescriptions used against prostate diseases, for example Harzol (Henneking & Heckers 1983).…”
Section: Resultsmentioning
confidence: 99%
“…Brie¯y, the 5-lipoxygenase assay was performed according to a previously described method (Kuhl et al 1984). Porcine polymorphonuclear lymphocytes (PMNL) were isolated by dextran sedimentation and the remaining erythrocytes removed by cell lysis.…”
Section: -Lipoxygenase Assaymentioning
confidence: 99%
“…The proposed mechanisms by which flavonoids result in improvements in clinical outcomes are equivocal and include: (i) support and protection of collagen-rich structures (Monboisse et al, 1984), (ii) reduction in concentration of metabolites known to increase vascular permeability, including the eicosanoid, leukotriene B4 (LTB4) (Kuhl et al, 1984), (iii) the documented enhancement of intracellular vitamin C (Bentsath et al, 1936a;Gabe and Parrot, 1951;Rusznyak et al, 1961) and (iv) protection of tissues from oxidative damage (Dewick, 1997) (Table 1). A combination of these effects is thought to result in an improvement in the integrity of the microvasculature.…”
Section: Introductionmentioning
confidence: 99%
“…Note that these different ª5-LO activeº compounds mentioned (and many more, see below) have a cathechol partial structure in common, and it is assumed that the combined ironchelating and antioxidant feature of this moiety is eventually responsible for uncoupling of the 5-LO catalytic cycle. Since the plant kingdom is a rich source for various polyphenols, flavonoids and coumarins, subsequent investigations addressed various representatives with phenolic or coumarin structure from different plants [91], [92], [93]. A second class of plant-derived 5-LO inhibitors constitutes compounds lacking reducing properties that may mimic fatty (arachidonic) acid structures including polyacetylenes, and triterpenes and thus, inhibit 5-LO activity by binding and/or competing at the substrate-binding site or at a hypothetical fatty acid-binding cleft of 5-LO.…”
Section: Inhibitors Of 5-lo Product Synthesis From Plant Originmentioning
confidence: 99%